Living With Imprecision

[...]there are ratios of atherogenic to antiatherogenic particles, including LDL-C/HDL-C and apolipoprotein B/apolipoprotein A (the major apolipoprotein of HDL), which, like non-HDL, try to express the net atherogenicity of the blood sample. [...]of agents now under development, we will soon have th...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 62; no. 8; pp. 740 - 741
Main Author LaRosa, John C., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 20.08.2013
Elsevier Limited
Subjects
Apolipoproteins
Cardiology
Cardiovascular
Cholesterol
Cholesterol, LDL - blood
Female
Friedewald equation
Humans
Internal Medicine
Lipids
Low density lipoprotein
low-density lipoprotein cholesterol
Male
very low-density lipoprotein cholesterol
Friedewald equation
low-density lipoprotein cholesterol
very low-density lipoprotein cholesterol
Online AccessGet full text

Cover

More Information
Summary:[...]there are ratios of atherogenic to antiatherogenic particles, including LDL-C/HDL-C and apolipoprotein B/apolipoprotein A (the major apolipoprotein of HDL), which, like non-HDL, try to express the net atherogenicity of the blood sample. [...]of agents now under development, we will soon have the ability to lower LDL-C levels well below 70 mg/dl.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2013.02.027